Compared with warfarin , apixaban resulted in a consistent reduction in stroke or systemic embolism in East Asian ( hazard ratio -LSB- HR -RSB- @ , @ % CI @-@ @ ) and non-East Asian ( HR @ , @ % CI @-@ @ ) patients ( interaction P = @ ) .